Systematische Analyse der Wirksamkeit und Sicherheit von Ezetimib


Rapid Assessment über die Wirksamkeit und Sicherheit von Ezetimib zur Sekundärprävention bei klinisch manifester Atherosklerose und/oder Diabetes mellitus mit hohem kardiovaskulären Risiko in Kombination mit Statinen.


Duration 01/09/2014 - 30/11/2014
Funding Sonstige
Program ---

Department for Evidence-based Medicine and Evaluation

Principle investigator for the project (Danube University Krems) Dr. Barbara Nußbaumer-Streit, MSc BSc
Project members Dr. Anna Glechner Dr. Angela Kaminski-Hartenthaler Irma Klerings, Dipl.KulturwissenschaftlerIn Dr. Peter Mahlknecht Dr. Barbara Nußbaumer-Streit, MSc BSc
Back to top


To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems, as well Google Maps for the use of depicting maps. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies and Google Maps. More information concerning privacy policy and data protection official.